Literature DB >> 22056862

Comment on 'Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab'.

J H Vallance.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22056862      PMCID: PMC3259575          DOI: 10.1038/eye.2011.193

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  1 in total

Review 1.  Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab.

Authors:  C H Meyer; F G Holz
Journal:  Eye (Lond)       Date:  2011-04-01       Impact factor: 3.775

  1 in total
  1 in total

1.  Authorship and the role of medical writers.

Authors:  A J Lotery
Journal:  Eye (Lond)       Date:  2011-11-04       Impact factor: 3.775

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.